Speaker

Jonathan Mapletoft, medical lead, specialty care and innovation team, GSK Canada

Jonathan Mapletoft is the medical lead for chronic hepatitis B within the specialty care and innovation team at GSK Canada. In his five years at GSK, he’s spent time in various therapeutic areas, including hepatology, rheumatology and infectious disease. Prior to joining GSK, Mapletoft spent time at the Canadian Institute for Health Research with the Institute of Infection and Immunity where he aided in the response to the COVID-19 pandemic. He completed his PhD at McMaster University in biomedical sciences.